What's Happening?
The Royal Canadian Air Force (RCAF) is currently evaluating the potential utility of collaborative combat aircraft (CCAs) for Canada, though no official decision has been made regarding their procurement. This comes as the Canadian government is investing
in cheaper drone programs through its Defence Drone Initiative (DDI). CCAs are uncrewed aircraft designed to operate alongside crewed fighter jets, utilizing AI to perform various tasks, including firing weapons and potentially engaging in aerial combat. While the technology is advancing, with tests showing drones like Anduril's Fury firing missiles and performing simulated combat tasks, Canada currently possesses no CCAs. The DDI, launched in July 2026, aims to accelerate the development and deployment of uncrewed and autonomous systems for the Canadian Armed Forces and Coast Guard, with initial contracts worth up to $50 million already awarded to increase drone deployment tenfold. This initiative has attracted 399 pre-qualified vendors, signaling a shift towards domestic production and volume in drone acquisition.
Why It's Important?
This development is significant for Canada's defense strategy and its position within evolving global military technology. While allies like the U.S., UK, and Australia are actively developing or acquiring CCAs, Canada's cautious approach reflects a debate over the integration of advanced autonomous systems and the ethical implications of AI in warfare. The DDI's focus on lower-cost, domestically produced drones indicates a strategy to build foundational capabilities and industrial capacity, rather than immediately investing in high-end, unproven CCA technology. This could foster growth in Canada's defense tech sector, particularly for AI and software vendors, but also raises questions about the country's ability to keep pace with adversaries and allies in advanced aerial combat capabilities. The emphasis on human control in lethal force decisions also highlights Canada's commitment to ethical warfare, potentially influencing international discussions on autonomous weapons.
What's Next?
In the near term, Canada is unlikely to announce any CCA procurement, as the RCAF is still in the study phase. The Defence Drone Initiative will continue to issue Requests for Proposals (RFPs) for robotic and autonomous systems over the next five years, leading to increased deployment of smaller, lower-cost drones. International discussions on autonomous weapons are ongoing, with diplomats meeting in Geneva to consider rules and a potential legally binding treaty by the end of 2026. Canada is expected to remain engaged in these talks, which could further shape its policy on human control over AI-powered weapons. Domestically, companies like Dominion Dynamics, which is developing its own CCA prototype, will likely seek government funding or contracts to advance their projects. Additionally, spending on counter-drone defenses is anticipated to rise in response to evolving threats from drone swarms.
Beyond the Headlines
The debate surrounding CCAs and AI in warfare extends beyond immediate military capabilities to profound ethical, legal, and sovereignty considerations. The question of human control over lethal autonomous weapons is central, with concerns about automation bias, the reliability of AI in varied environments, and accountability under international humanitarian law. Canada's stance on maintaining human command and control reflects a broader Western ethical framework, but also poses strategic challenges if adversaries do not adhere to similar limits. Furthermore, the reliance on foreign infrastructure for critical drone systems, including cloud services, chips, and satellite links, could compromise national sovereignty and introduce geopolitical vulnerabilities. The DDI's push for domestic production aims to mitigate these risks, fostering a self-reliant defense industrial base. This shift also highlights the increasing importance of data control, model ownership, and the ability to disable autonomous systems as critical procurement considerations.
